Cargando…

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines

Detalles Bibliográficos
Autores principales:	Westreich, Aaron, Zelarney, Pearlanne, Wechsler, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2023
Materias:	Clinical Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884606/ https://www.ncbi.nlm.nih.gov/pubmed/36720388 http://dx.doi.org/10.1016/j.jaip.2023.01.024

Ejemplares similares

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis
por: Liao, Shu-Yi, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis
por: Liao, Shu-Yi, et al.
Publicado: (2022)

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
por: Liu, Haolin, et al.
Publicado: (2023)

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
por: Liu, Haolin, et al.
Publicado: (2023)

Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine
por: Marcelino, João, et al.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2
por: Davila-Fernandez, Galicia, et al.
Publicado: (2022)

Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased
por: Diebold, Matthias, et al.
Publicado: (2022)

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
por: King, William W., et al.
Publicado: (2021)

Serological response to a single dose of a SARS-CoV-2 mRNA vaccine
por: Ramos, Angélica, et al.
Publicado: (2021)

Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria
por: Kamura, Yuya, et al.
Publicado: (2022)

Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine
por: Kuechler, Anna Sabrina, et al.
Publicado: (2023)

Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021)

Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis
por: Scheuermeyer, Frank X., et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA Vaccination
por: Altman, Natasha L., et al.
Publicado: (2022)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
por: Bettini, Emily, et al.
Publicado: (2021)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination
por: Castruita, Jose Alfredo Samaniego, et al.
Publicado: (2023)

First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination
por: Mahalingham, Aarani, et al.
Publicado: (2022)

Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB(*) infections
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination
por: Tauzin, Alexandra, et al.
Publicado: (2023)

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
por: Darling, Tamarand L., et al.
Publicado: (2022)

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
por: Ishii, Noritaka, et al.
Publicado: (2022)

Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines
por: Ritter, Alexander, et al.
Publicado: (2021)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine
por: de Lorenzi, Caroline, et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ck5gtr2448b7ats9i61d1a4r5